the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
26 May 2024 – Semaglutide is the active ingredient in the three Novo Nordisk drugs Ozempic, Rybelsus, and Wegovy that are being used for weight loss purposes. Thus, Ozempic, which was approved in 2017 by the FDA as a Type 2 diabetes treatment, …
Severe Stomach Conditions in Patients taking Semaglutide Read more »
December 11, 2023 – In June of 2021, the American Food and Drug Administration (FDA) approved the drug semaglutide for chronic weight management under the brand name Wegovy, ushering in a new era of obesity treatment. Since then, demand for …
Semaglutide Popularity: Serious Rare Adverse Effects Are Emerging Read more »
August 04, 2023 – We at thasso recently had an article (blog) on the much discussed and recently throughout the social media as wonder compound (drug) for weight loss promoted active ingredient Semaglutide in the form of the newly marketed product …
Is there living pharmacogenovigilance behind Semaglutide drugs? Read more »
July 11, 2010 – Do the people behind such products at all know what they do? On July 08, 2010, the FDA has issued the following warning concerning the Que She Herbal Supplement and its Undeclared Drug Ingredients: AUDIENCE: Consumer, …